Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
ALKEM Stock Analysis
Views
Red Flags
Positive
Strong price momentum
Analysts have been raising forward EPS estimates
High and stable ROE
High and stable operating margin
Moderate EPS growth and above median growth of industry
Low Debt to Equity, not much change from last year
Consistently pays dividend
Company is net cash
Negative
Expensive and at same valuation levels as industry median P/E
Low revenue growth and in line with median growth of industry
Low dividend yield
Neutral
Company's earnings are of moderate quality
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
ALKEM Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
ALKEM Bulk, Block & Insider Trades
ALKEM Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No capital change events found
Company Profile
Alkem Laboratories Ltd. is an India-based pharmaceutical company engaged in the development, manufacturing, and sale of pharmaceutical products. The Company operates in a single business segment-Pharmaceuticals. It produces branded generics, generic drugs, active pharmaceutical ingredients (APIs), a... Read More
Key personnel
Mr. Basudeo Narain SinghD
Executive Chairman of the Board
Dr. Vikas Gupta
Chief Executive Officer
Mr. Nitin Agrawal
President - Finance, Chief Financial Officer
Mr. Manish Narang
President - Legal, Chief Compliance Officer, Company Secretary
Mr. Sandeep SinghD
Managing Director, Executive Director
Mrs. Madhurima SinghD
Executive Director
Mr. Mritunjay Kumar SinghD
Executive Director
Mr. Sarvesh SinghD
Executive Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Alkem Laboratories Ltd.?
The current share price of Alkem Laboratories Ltd. is ₹ 5,799.65 as of 09 Jan 2026.
What is the PE ratio of Alkem Laboratories Ltd.?
The Price-to-Earnings (PE) ratio of Alkem Laboratories Ltd. is 29.37 as of the latest financial data.
What is the ROE and ROCE of Alkem Laboratories Ltd.?
Alkem Laboratories Ltd. has a Return on Equity (ROE) of 19.01% and a Return on Capital Employed (ROCE) of 16.45% as per the latest financial reports.
What is the market cap of Alkem Laboratories Ltd.?
The market capitalization of Alkem Laboratories Ltd. stands at ₹ 69,343.50 Cr.
What is the dividend yield of Alkem Laboratories Ltd.?
The dividend yield of Alkem Laboratories Ltd. is 0.78% based on the current market price.
What is the RSI of Alkem Laboratories Ltd.?
The Relative Strength Index (RSI) of Alkem Laboratories Ltd. is 63.17.
What is the FII and DII holding in Alkem Laboratories Ltd.?
Foreign Institutional Investors (FII) hold 9.47% and Domestic Institutional Investors (DII) hold 20.56% of Alkem Laboratories Ltd. shares.
What sector does Alkem Laboratories Ltd. belong to?
Alkem Laboratories Ltd. operates in the Healthcare sector.
What is the beta of Alkem Laboratories Ltd. stock?
The beta of Alkem Laboratories Ltd. stock is 0.68, indicating its volatility relative to the broader market.
